Clinical Trial Update: Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase I/II clinical trial evaluating neoadjuvant lapatinib in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tykerb (lapatinib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED